Serum homocysteine concentration is related to diabetes mellitus, but not to coronary heart disease, in Saudi Arabians

Diabetes, Obesity and Metabolism

Volumn 4, Issue 2, 2002, Pages 118-123

  Al Nozah, M ^a   Al Daghri, N ^b   Bartlett, W A ^b   Al Attas, O ^c   Al Maatouq, M ^a   Martin, S C ^b   Kumar, S ^b   Jones, A F ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Coronary heart disease; Diabetes mellitus; Homocysteine

Indexed keywords

HOMOCYSTEINE;

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROCHEMICAL ANALYSIS; FEMALE; GENDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; REGRESSION ANALYSIS; RISK FACTOR; SAUDI ARABIA; STATISTICAL ANALYSIS;

EID: 0036254390     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2002.00191.x     Document Type: Article

References (43)

1. The identification of homocysteine in the urine
2. Homocysteinuria: A new inborn error of metabolism associated with mental deficiency
3. Homocysteine theory of arteriosclerosis
4. Vascular pathology of homocyst(e)inemia: Implications for the pathogenesis of arteriosclerosis
5. Disorders of transulfuration
6. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease
7. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment
8. Neuropsychiatric disorders caused by cobalamine deficiency in the absence of anemia or macroytosis
9. Regulatory functions of the vascular endothelium
10. Urinary albumin excretion, cardiovascular disease and endothelial dysfunction in non-insulin-dependent duabetes mellitus
11. Glucose toxicity for human endothelial cells in culture: Delayed replication, disturbed cell cycle, and accelerated death
12. High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress
13. Role of oxidative stress in development of complications of diabetes
14. Oxidative stress and diabetic vascular complications
15. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats
16. Receptor for advanced glycation end products (AGES) has central role in vessel wall interactions and gene activation in activation in response to circulating AGE proteins
17. The effect of intensive treatment and progression of long-term complication in insulin-dependent diabetes mellitus
18. Effect of intensive diabetes management on diabetes control and diabetes complications trial
19. Effects of vitamin B12, Folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations
20. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicans
21. Plasma homocysteine and severity of atherosclerosis in young paients with lower-limb atherosclerotic disease
22. Lack of association between plasma homocysteine level and microangiopathy in type 1 diabetes mellitus
23. Increased levels of plasma homocysteine are associated with nephropathy but not severe retinopathy in type 1 diabetes mellitus
24. Hyperhomocysteinaemia, a risk factor for atherosclerosis in chronic uremic patients
25. Hyperhomocysteinaemia and the risk for vascular disease in hemodialysis patients
26. Measurement of plasma homocysteine by HPLC with electrochemical detection
27. Plasma homocysteine concentrations in patients with type1 diabetes
28. Hyperhomocysteinaemia following a methionine load in non-insulin-dependent diabetes and macrovascular disease
29. Hyperhomocysteinaemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus
30. Diabetes mellitus
31. Hyperhomocysteinaemia and endothelial dysfunction in IDDM
32. Type 1 diabetes mellitus and homocysteine
33. Plasma homocysteine concentrations in type II diabetic paients in India: Relationship to body weight
34. Effect of streptozocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat
35. Regulation of homocysteine metabolism
36. Relation of serum homocysteine and lipoprotein (a) concentrations to atherosclerotic disease in a prospective Finnish population based study
37. Homocysteine, risk of cardiovascular events in the multiple risk factor intervention trial
38. Total plasma homocysteine and cardiovascular risk profile
39. Population variation and genetics of plasma homocysteine level
40. Total homocysteine in plasma and amniotic fluid of pregnant women
41. Rapid HPLC determination of total homocysteine and other thiol in serum and plasma: Sex differences and correlation with cobalmin and folate level in healthy subjects
42. Vitamin status and intake as primary determinants of homocysteineamia in an elderly population
43. Age dependency of cystathione beta synthase activity in human fibroblasts in homocysteineamia and atherosclerotic vascular disease